March 14, 2024 | By Michelle Jones | Clinical Research, Clinical Trials, Liver, Liver Disease, Liver Health, NASH, News & Events
Today, we’re talking about some exciting news for people battling fatty liver disease, specifically Nonalcoholic Steatohepatitis (NASH) a condition where too much fat is stored in the liver, causing inflammation and damage. NASH is a tricky disease because it’s often …
March 14, 2024 | By Michelle Jones | News & Events, Clinical Trials, Liver, Liver Disease, Liver Health, NASH | Promising Advance in Treatment, resmetirom, Rezdiffra
Nonalcoholic Steatohepatitis (NASH) (now known as Metabolic Dysfunction-Associated Steatohepatitis or MASH) represents a significant and growing challenge in clinical practice, with its progression to cirrhosis and hepatocellular carcinoma posing serious risks for patients. The exciting new conditional commercial launch of …
June 15, 2023 | By John Raslavsky | Cirrhosis, Clinical Trials, Liver Disease, Liver Health, Volunteering in Research | Cirrhosis, Clinical research, Clinical trials, Fatty Liver Disease, liver health, Liver research, Liver Scarring
Liver cirrhosis is a chronic and potentially life-threatening condition affecting many worldwide and in Arizona. Historically, men have been disproportionately affected by liver cirrhosis. Studies show that death rates amongst men with liver cirrhosis are twice as high as women. …
April 7, 2022 | By John Raslavsky | Clinical Trials, Liver Disease, Minority Participation in Liver Research | Blog, Diversity in research, Fatty Liver Disease, NAFLD, NASH, National Minority Health Month
April is National Minority Health Month (NMHM), a time to raise awareness about health disparities that affect people from racial and ethnic minority groups. Liver disease is growing in prevalence in the Hispanic population. It is also a leading cause …
February 28, 2022 | By John Raslavsky | Clinical Trials, Liver Health | Blog, liver disease research, NAFLD, NASH
There’s a lot of love to celebrate during the month of February. However, some of the things we love are bad for our overall health. One of these areas is our obsession with the “western diet,” which is high in …
January 31, 2022 | By John Raslavsky | Clinical Trials, Liver | Blog, liver health, Liver research, NAFLD, NASH
You can start this year on the right foot by taking proactive steps for your health and well-being. If you’ve been diagnosed with liver disease, keeping your liver healthy is essential. It’s a new year, and it’s time to set …
October 14, 2021 | By John Raslavsky | Clinical Trials, Fibroscan, Liver Awareness Month | Blog, NAFLD, NASH
The liver is one of the most vital organs in our bodies. It is impossible to survive without the life-sustaining functions it provides. Understandably, how well we take care of our liver impacts its ability to function properly. National Liver …
August 26, 2021 | By John Raslavsky | Cirrhosis, Clinical Trials, Liver Disease | Blog, NAFLD, NASH
Cirrhosis is when the permanent scarring of the liver has replaced the healthy tissue. While cirrhosis is most often associated with chronic alcohol consumption, it is brought about by many types of liver disease. Here’s how you get from liver disease …
August 4, 2021 | By John Raslavsky | Clinical Trials, Liver Disease | Blog, Caregiving, Clinical research, NAFLD, NASH
Having liver disease affects the person with it but also loved ones around them. Often a family member or friend fills the role of meeting a variety of physical and emotional needs. If you are a caregiver for someone with …
July 13, 2021 | By John Raslavsky | Clinical Trials, Liver Disease | Blog, Clinical trials, NAFLD, NASH
The number of U.S. adults with non-alcoholic fatty liver disease (NAFLD) currently sits around 25%. Approximately 2-3% of them will go on to develop non-alcoholic steatohepatitis (NASH). NASH is a more severe form of NAFLD and can lead to fibrosis, …